Abstract:The conversion of native soluble proteins into insoluble amyloid fibrils that are rich in cross β-sheet structure is associated with a variety of neurodegenerative diseases. It has recently become apparent that smaller oligomers formed during the early stages of amyloid fibril formation may be primarily responsible for the toxicity in amyloid diseases. Traditional ensemble techniques have limitations in characterization of oligomers due to the metastable and heterogeneous nature of these prefibrillar species. Single molecule fluorescence spectroscopy allows the conformational dynamics of individual biomolecules to be investigated, revealing properties that may be averaged in the ensemble experiment. It is therefore extremely powerful for identification and characterization of the low-populated, heterogeneous and transient species formed during fibril assembly. Combining single molecule fluorescence with kinetic modeling can provide quantitative information regarding the microscopic steps in amyloid formation. Here we have applied single molecule fluorescence resonance energy transfer to investigate in detail the intermolecular assembly and aggregation process of the yeast prion protein Ure2. Oligomerization during the initial lag phase was observed, and two types of Ure2 oligomers with different assembly modes were identified. Furthermore, using theoretical analysis combined with single molecule and ensemble kinetic data, we describe the formation and depletion pathway of oligomers, and propose a multi-step mechanism for Ure2 fibril formation, in which initial oligomerization is followed by conformational conversion to β-sheet containing oligomers that are then able to grow to form mature amyloid fibrils. We also show directly that secondary nuclei do not form, and that fragmentation is therefore responsible for the autocatalytic behavior of Ure2, in contrast to the mechanism of the amyloid formation of Aβ peptide. These results shed light on the potential origin of differences in cytotoxicity between functional and disease-related amyloids.

Molecular Dynamics Simulations on the Oligomer-Formation Process of the GNNQQNY Peptide from Yeast Prion Protein Sup35.

Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35

A variational model for oligomer-formation process of GNNQQNY peptide from yeast prion protein Sup35.

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Structural, Thermodynamical, and Dynamical Properties of Oligomers Formed by the Amyloid NNQQ Peptide: Insights from Coarse-Grained Simulations

Quantitative Study of the Oligomerization of Yeast Prion Sup35NM Proteins.

Oligomerization of Yeast Prion Sup35NM

Insight into Sup35(7-13) Misfolding and Interactions Using Molecular Dynamics Simulation

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

Molecular Dynamics Simulations of Alanine Rich Beta-Sheet Oligomers: Insight into Amyloid Formation.

Self-assembly of amyloid-forming peptides by molecular dynamics simulations.

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

Molecular Mechanism of the Early Stage of Amyloidogenic Hexapeptides (NFGAIL) Aggregation

Stabilities and Structures of Islet Amyloid Polypeptide (IAPP22-28) Oligomers: from Dimer to 16-Mer.

Exploring the Early Steps of Aggregation of Amyloid-Forming Peptide Kffe

Structural Diversity and Initial Oligomerization of PrP106–126 Studied by Replica-Exchange and Conventional Molecular Dynamics Simulations

Revealing the Mechanism of Amyloid Fibril Formation by Combined Single Molecule FRET and Kinetic Modeling

Crucial role of non-specific interactions in amyloid nucleation

Molecular Dynamics Simulations of Alzheimer Abeta40 Elongation and Lateral Association.

Self-Assembling ABETA(30-36) Peptides: A Combined All-Atom and Coarse-Grained Simulation Study

Competition between crystal and fibril formation in molecular mutations of amyloidogenic peptides